GenFleet Therapeutics (Shanghai) (HKSE:02595) Beta: N/A (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02595 GenFleet Therapeutics (Shanghai) Inc HKSE:02595
10 GF Score
Price HK$27.60
! 3 Warning Signs
View Full Analysis

What is GenFleet Therapeutics (Shanghai) Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-04), GenFleet Therapeutics (Shanghai)'s Beta is Not available.

GenFleet Therapeutics (Shanghai)  (HKSE:02595) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

GenFleet Therapeutics (Shanghai) Beta Related Terms

GenFleet Therapeutics (Shanghai) Beta Historical Data

* Premium members only.

The historical data trend for GenFleet Therapeutics (Shanghai)'s Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenFleet Therapeutics (Shanghai) Beta Chart

GenFleet Therapeutics (Shanghai) Annual Data
Trend Dec23 Dec24 Dec25
Beta
0.00 0.00 0.00

GenFleet Therapeutics (Shanghai) Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Beta 0.00 0.00 0.00 0.00 0.00
HKSE:02595
10GF Score
GenFleet Therapeutics (Shanghai) Inc HKSE:02595
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GenFleet Therapeutics (Shanghai) Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

GenFleet Therapeutics (Shanghai) Business Description

Other Exchanges Y3L:Germany
Address 1206 Zhangjiang Road, Floors 2nd, 3rd, 4th, and 5th, Building 8, Shanghai Pilot Free Trade Zone, Shanghai, CHN, 201203
GenFleet Therapeutics (Shanghai) Inc Company is a clinical-stage biotechnology company. The Company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment.
10GF Score

Get the complete analysis for HKSE:02595

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$27.60
Price